Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04339101
What this trial is testing

Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

Who this might be right for
Acute LeukemiaHematologic and Lymphocytic DisorderMyelodysplastic Syndrome+2 more
City of Hope Medical Center 59
Testing effectiveness (Phase 2)Looking for participantsNCT07400328
What this trial is testing

Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients

Who this might be right for
Oral MucositisStomatitisGastrointestinal Mucositis+1 more
The First Affiliated Hospital of Soochow University 22
Testing effectiveness (Phase 2)Study completedNCT04191187
What this trial is testing

Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBiphenotypic Acute Leukemia+15 more
H. Lee Moffitt Cancer Center and Research Institute 34
Not applicableStudy completedNCT00423709
What this trial is testing

Allogeneic Blood Stem Cell Transplantation

Who this might be right for
Hodgkin's Disease
M.D. Anderson Cancer Center 46
Large-scale testing (Phase 3)UnknownNCT03086993
What this trial is testing

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Bile Duct CancerIntrahepatic Cholangiocarcinoma
Delcath Systems Inc. 295
Large-scale testing (Phase 3)Study completedNCT00551928
What this trial is testing

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaNewly Diagnosed Patients
Fondazione EMN Italy Onlus 402
Early research (Phase 1)Study completedNCT00003899
What this trial is testing

Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00641030
What this trial is testing

Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04904588
What this trial is testing

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMixed Phenotype Acute Leukemia+5 more
Center for International Blood and Marrow Transplant Research 300
Not applicableStudy completedNCT01383759
What this trial is testing

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Who this might be right for
Light Chain Deposition Disease (LCDD or MIDD)Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD)Monoclonal Immunoglobulin Deposition Disease (MIDD)+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002594
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors

Who this might be right for
Brain TumorCentral Nervous System Tumor
Children's Oncology Group 31
Early research (Phase 1)WithdrawnNCT00972101
What this trial is testing

Infusion of Expanded Cord Blood T Cells

Who this might be right for
Stem Cell TransplantationLeukemiaLymphoma+1 more
M.D. Anderson Cancer Center
Early research (Phase 1)Ended earlyNCT04115956
What this trial is testing

A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Oncopeptides AB 6
Testing effectiveness (Phase 2)WithdrawnNCT02114502
What this trial is testing

Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00317811
What this trial is testing

Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Oncotherapeutics 35
Early research (Phase 1)Not Yet RecruitingNCT05903937
What this trial is testing

Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases

Who this might be right for
Uveal MelanomaMetastatic Cutaneous Melanoma
Vastra Gotaland Region 6
20